Cooperative Agreement IDSEP230061

Federal Cooperative Agreement Summary Award Overview: The National Science Foundation (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084) awarded a $1.25 million cooperative agreement to Phaxtec, Inc. on August 15, 2025, for an SBIR Phase II project focused on developing biodegradable biopolymer coatings for food service packaging. The project, which runs through July 31, 2027, will be conducted at the company's facility in Wake Forest, North Carolina. Products and Services...

Federal Cooperative Agreement Summary Award Details: Xheme Inc., a Newton, Massachusetts-based advanced materials science company, received a $1.19 million Cooperative Agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) on September 1, 2025, with an anticipated completion date of August 31, 2027. Under this Small Business Technology Transfer (STTR) Phase II project, Xheme is developing a next-generation, non-toxic blood bag to...

Federal Cooperative Agreement Summary Promedix, Inc. received $1,144,758 in Small Business Innovation Research (SBIR) Phase II funding from the National Science Foundation (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084) effective September 1, 2025 through August 31, 2027. The company is developing an automated electronic measurement device designed to rapidly and objectively quantify capillary refill time as a diagnostic indicator for sepsis. The novel system utilizes an...

Federal Cooperative Agreement Summary Insu Health Design Inc. received a $998,527 Cooperative Agreement awarded on May 15, 2025, by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084). The award supports a Small Business Innovation Research (SBIR) Phase II project focused on developing and commercializing an advanced temperature control system for storing and transporting temperature-sensitive materials, including medications,...

Federal Cooperative Agreement Summary Inaedis, Inc. received a $1.25M Cooperative Agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships program (CFDA 47.084), awarded June 1, 2025, with completion targeted for May 31, 2027. The award supports an SBIR Phase II project to develop and scale a Rapid Room-Temperature Aerosol Dehydration (RTAD) platform technology for stabilizing biopharmaceutical formulations at room temperature. This innovation addresses...

The National Science Foundation (NSF) awarded a $878,296 Cooperative Agreement to Surfplasma Inc., a minority-owned small business based in Gainesville, FL, to develop a rapid, low-temperature plasma prototype for disinfecting personal protective equipment (PPE), medical devices, food products and other materials from pathogens like COVID-19. The project, funded under NSF's Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to deliver a market-ready sterilization solution...

This SBIR Phase II Cooperative Agreement, awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, is funding the development of manufacturing standards and processes for producing textile-derived recycled polyester (RPET) feedstock. The $994,863 award, which runs from March 2025 to February 2027, aims to enable the commercial-scale production of this highly desired but currently unavailable material for the textile industry....

Federal Cooperative Agreement Award Summary Osmopure Technologies, Inc., a small disadvantaged business based in Boulder, Colorado, received a $1.525M Cooperative Agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) for the period September 1, 2025 through August 31, 2028. The award supports the development and scaling of pressure-driven distillation membrane technology for ultrapure water production, specifically targeting...

Federal Cooperative Agreement Summary Landsdowne Labs LLC received a $1.0 million Small Business Innovation Research (SBIR) Phase II cooperative agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), awarded October 1, 2025, with completion targeted for September 30, 2027. The awardee will develop and deliver safer coin cell battery casings engineered to passively deactivate upon exposure to bodily fluids, thereby mitigating the...

This National Science Foundation (NSF) Cooperative Agreement award under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $1,000,000 in funding to Amphix Bio Inc. to develop scalable manufacturing methods for a novel supramolecular polymer-based spinal implant. The project aims to enable safer, simpler, and lower-cost spinal fusion surgery by advancing this regenerative medicine technology. The key deliverables include scaling up the production of the...